1 / 6

PRRT Treatment for Neuroendocrine Tumour

Several researches and clinical trials have shown that Peptide Receptor Radionuclide Therapy (PRRT) is an exciting and effective advancement in the treatment of Neuroendocrine Tumors (NETs).<br>

ManavSadhwani
Download Presentation

PRRT Treatment for Neuroendocrine Tumour

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Several researches and clinical trials have shown that Peptide Receptor Radionuclide Therapy (PRRT) is an exciting and effective advancement in the treatment of Neuroendocrine Tumors (NETs).

  2. Peptide Receptor Radionuclide Therapy (PRRT) is a recommended treatment option for patients with metastatic inoperable neuroendocrine tumor(s) which are positive on Somatostatin Receptor Imaging (Ga68-DOTATATE PET CT). It is also recommended for NET patients who cannot undergo surgery and for patients who are not responding to other therapies.

  3. The objective of Peptide Receptor Radionuclide Therapy (PRRT) is to provide symptom relief, slow down or stop tumor progression, to increase survival and improve quality of life.

  4. Peptide receptor radionuclide therapy (PRRT) is fast proving to be paradigm shifting approach to the treatment of neuroendocrine tumors.

  5. For more information on PRRT, do call us at +91 98111 27080, or write to us at info@nuclearmedicinetherapy.in or visit https://nuclearmedicinetherapy.in/

  6. For more information on PRRT, do call us at +91 98111 27080, or write to Dr. Ishita B. Sen at dr.ishitasen@nuclearmedicinetherapy.inor consult us at https://nuclearmedicinetherapy.in/consult-us

More Related